Celiac.com 03/14/2017 - Recent studies of adult celiacs have suggested that complete, not just partial, mucosal recovery and healing is possible, but, in many cases, may take longer than is currently understood.
Recently Dr. Hugh James Freeman of the Department of Medicine, Gastroenterology, University of British Columbia, Vancouver, BC, Canada, conducted a study to assess healing time in celiac patients. In this study, 182 patients (60 males, 122 females) referred for evaluation of symptoms, including diarrhea and weight loss, were selected only if initial biopsies showed characteristic inflammatory changes with severe architectural disturbance.
All patients were treated with a strict gluten-free diet, and diet compliance was regularly monitored. Up to 90% or more of patients showed...

Celiac.com 10/13/2017 - Tissue transglutaminase (tTG) immunoglobulin A (IgA) testing is a sensitive adjunct to the diagnosis of coeliac disease. The threshold for positivity was developed for diagnosis, with negative results reported as below the reference value (<4 U/mL).
A team of researchers recently set out to investigate if an undetectable tissue transglutaminase IgA antibodies (tTG IgA<1.2 U/mL) is more predictive of healing compared to patients with negative but detectable serology (1.2-3.9 U/mL).
The research team included H. Fang, K. S. King, J. J. Larson, M. R. Snyder, T. T. Wu, M. J. Gandhi, and J. A. Murray. They are variously affiliated with the Department of Medicine, the Division of Gastroenterology and Hepatology, the Division of Anatomic Pathology, the Division...

Celiac.com 05/08/2020 - Can someone with celiac disease really heal?
This is sort of how I see the villi of someone with Celiac disease - flattened with big gaps between.
I missed this one, but in November 2019, there were some results from the Nexvax study involving endoscopic biopsies. It confirms what we already knew - blood tests and biopsy results are unrelated and celiac patients are sicker that they should be.
The study lists that 93 patients underwent endoscopic biopsies as part of their participation in the Nexvax2 clinical trial. Only SIX patients had Marsh 0 or 1 damage. Marsh 0 or 1 damage is considered normal. Thirty had Marsh 2 damage and fifty-six were Marsh 3a or 3b. The good news is that some people had complete healing. But out of 93 patients, 86...